MYC-Induced Replicative Stress: A Double-Edged Sword for Cancer Development and Treatment
- PMID: 34201047
- PMCID: PMC8227504
- DOI: 10.3390/ijms22126168
MYC-Induced Replicative Stress: A Double-Edged Sword for Cancer Development and Treatment
Abstract
MYC is a transcription factor that controls the expression of a large fraction of cellular genes linked to cell cycle progression, metabolism and differentiation. MYC deregulation in tumors leads to its pervasive genome-wide binding of both promoters and distal regulatory regions, associated with selective transcriptional control of a large fraction of cellular genes. This pairs with alterations of cell cycle control which drive anticipated S-phase entry and reshape the DNA-replication landscape. Under these circumstances, the fine tuning of DNA replication and transcription becomes critical and may pose an intrinsic liability in MYC-overexpressing cancer cells. Here, we will review the current understanding of how MYC controls DNA and RNA synthesis, discuss evidence of replicative and transcriptional stress induced by MYC and summarize preclinical data supporting the therapeutic potential of triggering replicative stress in MYC-driven tumors.
Keywords: DNA replication; MYC; cancer therapy; replicative stress; transcription; transcription stress.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
CDK12 controls transcription at damaged genes and prevents MYC-induced transcription-replication conflicts.Nat Commun. 2024 Aug 18;15(1):7100. doi: 10.1038/s41467-024-51229-5. Nat Commun. 2024. PMID: 39155303 Free PMC article.
-
The cohesin complex prevents Myc-induced replication stress.Cell Death Dis. 2017 Jul 27;8(7):e2956. doi: 10.1038/cddis.2017.345. Cell Death Dis. 2017. PMID: 28749464 Free PMC article.
-
Transcriptional control of DNA replication licensing by Myc.Sci Rep. 2013 Dec 6;3:3444. doi: 10.1038/srep03444. Sci Rep. 2013. PMID: 24309437 Free PMC article.
-
Myc induced replicative stress response: How to cope with it and exploit it.Biochim Biophys Acta. 2015 May;1849(5):517-24. doi: 10.1016/j.bbagrm.2014.04.008. Epub 2014 Apr 13. Biochim Biophys Acta. 2015. PMID: 24735945 Review.
-
MYC and the control of DNA replication.Cold Spring Harb Perspect Med. 2014 Jun 2;4(6):a014423. doi: 10.1101/cshperspect.a014423. Cold Spring Harb Perspect Med. 2014. PMID: 24890833 Free PMC article. Review.
Cited by
-
Splice-switch oligonucleotide-based combinatorial platform prioritizes synthetic lethal targets CHK1 and BRD4 against MYC-driven hepatocellular carcinoma.Bioeng Transl Med. 2022 Sep 3;8(1):e10363. doi: 10.1002/btm2.10363. eCollection 2023 Jan. Bioeng Transl Med. 2022. PMID: 36684069 Free PMC article.
-
Increased Replication Stress Determines ATR Inhibitor Sensitivity in Neuroblastoma Cells.Cancers (Basel). 2021 Dec 10;13(24):6215. doi: 10.3390/cancers13246215. Cancers (Basel). 2021. PMID: 34944835 Free PMC article.
-
Polyploidy and Myc Proto-Oncogenes Promote Stress Adaptation via Epigenetic Plasticity and Gene Regulatory Network Rewiring.Int J Mol Sci. 2022 Aug 26;23(17):9691. doi: 10.3390/ijms23179691. Int J Mol Sci. 2022. PMID: 36077092 Free PMC article. Review.
-
Attenuating iPSC reprogramming stress with dominant-negative BET peptides.iScience. 2022 Dec 28;26(1):105889. doi: 10.1016/j.isci.2022.105889. eCollection 2023 Jan 20. iScience. 2022. PMID: 36691621 Free PMC article.
-
c-myc-mediated upregulation of NAT10 facilitates tumor development via cell cycle regulation in non-small cell lung cancer.Med Oncol. 2022 Jul 14;39(10):140. doi: 10.1007/s12032-022-01736-6. Med Oncol. 2022. PMID: 35834140
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources